戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 dditive declines in blood pressure and total peripheral resistance.
2 pulsatile load and concurrently lowers total peripheral resistance.
3 sure, occurs as the consequence of increased peripheral resistance.
4 despite reduced diastolic pressure and total peripheral resistance.
5 ystem, and increased vascular tone and total peripheral resistance.
6 lity, systemic compliance, stroke volume and peripheral resistance.
7 ormal, where it is quickly reflected off the peripheral resistance.
8 rterial enlargement in response to increased peripheral resistance.
9 cant increases in SS RBC adhesion and in the peripheral resistance.
10 ke volume, possibly as a result of decreased peripheral resistance.
11 ut (5.5 vs. 4.9 l/min; P < 0.001), and lower peripheral resistance (1,487 vs. 1,666; P = 0.01), paral
12 15% vs. -5 +/- 10%), and a lower decrease in peripheral resistance (-17 +/- 12% vs. -26 +/- 12%) (p <
13 n increase in blood pressure (43%) and total peripheral resistance (65%) without any change in heart
14 cts peripheral resistance to blood flow, and peripheral resistance affects DBP.
15 anged significantly with a decrease in total peripheral resistance and an increase in common femoral
16 d by elevated heart rate and decreased total peripheral resistance and arterial blood pressure.
17 on were hypotensive, with decreases in total peripheral resistance and filtration fraction on day 1 i
18 rolled for, hypertensive subjects had higher peripheral resistance and lower arterial compliance than
19 late vasoconstriction, which increases total peripheral resistance and mean arterial pressure.
20                                              Peripheral resistance and peak filling rate were unchang
21                                        Total peripheral resistance and perivascular fibrosis in the h
22 during EFP than MLP (P = 0.030), while total peripheral resistance and plasma noradrenaline were not
23 nts present with low cardiac output and high peripheral resistance and that they respond poorly to fl
24 pressure and is a fundamental determinant of peripheral resistance and, hence, organ perfusion and sy
25 high rate of LV hypertrophy, in spite of low peripheral resistances and low-to-normal blood pressure,
26                         Cardiac index, total peripheral resistance, and blood volume were not differe
27  volume, increased cardiac output, decreased peripheral resistance, and increased uteroplacental bloo
28 stemic oxygen delivery, stroke volume, total peripheral resistance, and organ blood flow in the liver
29 (P < 0.001), diastolic blood pressure, total peripheral resistance, and stroke volume compared with w
30 ate, preload, and cardiac output; decreasing peripheral resistance; and increasing ventricular compli
31 ecause endothelial dysfunction and increased peripheral resistance are hallmarks of hypertension, det
32 between central control of vascular flow and peripheral resistance are unclear.
33 ar volumes and end-systolic elastance (Ees), peripheral resistance, arterial elastance (Ea), arterial
34       Autonomic sympathetic nerves innervate peripheral resistance arteries, thereby regulating vascu
35  not Dex impaired NO-dependent relaxation of peripheral resistance arteries.
36 ationship between large artery stiffness and peripheral resistance artery function.
37 rs and identified the systemic and pulmonary peripheral resistance as being critical parameters for a
38 lood pressure is acutely controlled by total peripheral resistance as determined by the diameter of s
39 f altered arterial stiffness versus impaired peripheral resistance but is not superior to SBP+DBP in
40 ut and decreases in left atrial pressure and peripheral resistance but without eliciting a supplement
41 sure, portal pressure, cardiac output, total peripheral resistance, central blood volume, and extrace
42 al hemodynamics were determined by the total peripheral resistance, common femoral artery flow, and a
43 er (P = 0.09), heart rate was similar, total peripheral resistance decreased (2172 +/- 364 vs. 2543 +
44 nfusion before any symptoms developed, total peripheral resistance decreased 24% +/- 20% in group II
45 to tilt before any symptoms developed, total peripheral resistance decreased 9% +/- 14% in group I fr
46                      Cardiac index and total peripheral resistance decreased in MSA patients by 33.4+
47                                        Total peripheral resistance decreased with rosuvastatin in bot
48 EP group and associated with increased total peripheral resistance (difference in means, 96.4 [95% co
49 s include increased cardiac work with normal peripheral resistance, diffuse slowing on electroencepha
50 a means for maintenance of vascular tone and peripheral resistance during hibernation.
51                                        Total peripheral resistance during tilt post flight was higher
52 tput, and calculated stroke volume and total peripheral resistance, during supine rest and 10 min of
53 ined by LV end-diastolic dimension and total peripheral resistance estimated by thoracic impedance.
54 to 86.9 +/- 21.7 ml (P = 0.06) and increased peripheral resistance from 1106 +/- 246 to 1246 +/- 222
55 autonomic nerves may impair control of total peripheral resistance giving rise to symptomatic orthost
56  EC size, occlusion of capillaries, elevated peripheral resistance, heart failure, and death.
57 sure (Normal: p < 0.001; HF: p < 0.001), and peripheral resistance (HF: p < 0.001), and transiently i
58 subjects, accompanied by a decrease in total peripheral resistance in 16 of them (64%, group A).
59 In vivo, human U-II markedly increases total peripheral resistance in anaesthetized non-human primate
60 aptation may contribute to the regulation of peripheral resistance in eNOS-KO mice.
61 t dilatation may contribute to the increased peripheral resistance in hypertension.
62 es to the elevation of wall shear stress and peripheral resistance in hypertension.
63 rdiac output (CO) but minor changes in total peripheral resistance in saline-treated rats.
64 ntry communication) and physiologic factors (peripheral resistance in the branch vessels, pump output
65 ge of factors: one key element of control is peripheral resistance in tissue capillary beds.
66 he true-lumen outflow caused by lowering the peripheral resistance in true-lumen branch vessels.
67 (P<0.05) compared with baseline, while total peripheral resistance increased (P<0.05).
68  Na+ intake, while baseline CO decreased and peripheral resistance increased in this group.
69 nd 1.15 versus 1.02 mm Hg/mL x m2) and total peripheral resistance index (3027 and 2805 versus 2566 d
70 n cardiac index, a 28% increase in the total peripheral resistance index (p < .01), and a 33% decreas
71                                    The total peripheral resistance index and stroke volume index tend
72 ed with increases in both cardiac output and peripheral resistance index.
73                               This increased peripheral resistance is the result of an increased acti
74 intact, (ii) both calcification and enhanced peripheral resistance lead to reduced flow rates, reduce
75                               Although total peripheral resistance markedly increased, mean arterial
76 mean arterial pressure of 18 mm Hg and total peripheral resistance of 665 AU and increases in heart r
77 roximately 20 mm Hg and an increase in total peripheral resistance of approximately 30%.
78 ressure (7 +/- 4 mmHg, P <= 0.001) and total peripheral resistance (P = 0.013) concomitantly with a r
79 01) while accentuating the increase in total peripheral resistance (P=0.012).
80 decreases in left atrial pressure (P<0.001), peripheral resistance (P=0.014), and hematocrit (P<0.001
81 on with a 94.5 dynes x sex/cm(5) lower total peripheral resistance (P=0.0368).
82 ries, but this drop can be offset by greater peripheral resistance, provided left ventricular functio
83 women relative wall thickness (r = 0.11) and peripheral resistance (r = -0.17).
84                               Although total peripheral resistance remains decreased, Na+ retention c
85 duced microvascular blood flow and increased peripheral resistance, suggesting that vasodilatory decr
86 epsis), cardiac output, stroke volume, total peripheral resistance, systemic oxygen delivery, and org
87 oth muscle cells of a primary determinant of peripheral resistance - the small mesenteric artery.
88                            Viscosity affects peripheral resistance to blood flow, and peripheral resi
89 cially the visceral type, is associated with peripheral resistance to insulin actions and hyperinsuli
90 modalities, such as exercise, may overcome a peripheral resistance to insulin, thus preventing GDM or
91                                              Peripheral resistance to leptin due to its impaired brai
92 ng leptin and have the potential to induce a peripheral resistance to leptin, similar to the central
93 roke volume (SV), cardiac output (CO), total peripheral resistance (TPR) and arterial compliance to a
94 tivity (MSNA) is positively related to total peripheral resistance (TPR) and inversely related to car
95 asures of preejection period (PEP) and total peripheral resistance (TPR) in healthy black (n=76) and
96 ed, whereas heart rate (HR), MSNA, and total peripheral resistance (TPR) increased during HUT (all P<
97                                        Total peripheral resistance (TPR) increased during LBNP in bot
98                               Baseline total peripheral resistance (TPR) was not different between th
99  decrease in cardiac contractility and total peripheral resistance (TPR) were similar in TRPV(1)(+/+)
100 roke volume (SV), heart rate (HR), and total peripheral resistance (TPR), in 163 patients with tilt-i
101 tients with VAH show a greater rise in total peripheral resistance (TPR), suggesting a compensatory m
102 a sympathetically-mediated increase in total peripheral resistance (TPR).
103 ; n = 12) underwent assessments of BP, total peripheral resistance (TPR; Modelflow) and MSNA action p
104 Microvascular blockage resulted in increased peripheral resistance units (PRU).
105 d action of nitric oxide and endothelin-1 in peripheral resistance vessels of patients with syndrome
106                                        Total peripheral resistance was calculated from mean arterial
107 2 +/- 0.40 l min(-1), P = 0.01), while total peripheral resistance was greater (1327 +/- 117 vs. 903
108                                   Supine leg peripheral resistance was greater than control resistanc
109 ght with CFD than in those with PFD, whereas peripheral resistance was not significantly different.
110  volume (r=0.88+/-0.13, P<0.05), while total peripheral resistance was related to MSNA during 45 min
111 with control rats, but the increase in total peripheral resistance was significantly attenuated.
112               In the other 9 subjects, total peripheral resistance was well maintained even at presyn
113 eart rate, mean arterial pressure, and total peripheral resistance were greater, whereas cardiac outp
114                 Upright heart rate and total peripheral resistance were greater, whereas stroke volum
115                     Blood pressure and total peripheral resistance were higher during rest and tiltin
116 decrease in diastolic pressure and estimated peripheral resistance were observed in troglitazone-trea

 
Page Top